Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY(2024)

引用 0|浏览15
暂无评分
关键词
cancer,immune checkpoint inhibitors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要